Evista and Lactulose drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Evista (raloxifene hydrochloride) and Lactulose (lactulose). Common drug interactions include fall among females.

The phase IV clinical study analyzes what interactions people have when they take Evista and Lactulose. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.

What is Evista?

Evista has active ingredients of raloxifene hydrochloride. It is often used in osteoporosis. eHealthMe is studying from 25,891 Evista users. Check the latest studies of Evista.

What is Lactulose?

Lactulose has active ingredients of lactulose. It is often used in constipation. eHealthMe is studying from 46,960 Lactulose users. Check the latest studies of Lactulose.

On Jul, 06, 2026

38 people who take Evista and Lactulose together, and have interactions are studied.

What are the common drug interactions of Evista and Lactulose, by gender? *:

female:

Fall
Pruritus (severe itching of the skin)
Dyspnoea (difficult or laboured respiration)
Fluid overload (too much fluid in the blood)
Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Nausea (feeling of having an urge to vomit)
Oxygen saturation decreased
Pancreatitis bacterial (inflammation of pancreas caused by bacterial infection)

male:

n/a

What are the common drug interactions of Evista and Lactulose, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Bradycardia (abnormally slow heart action)
Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream)

50-59:

Injection site erythema (redness at injection site)
Platelet count decreased

60+:

Fall
Abdominal distension
Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Oxygen saturation decreased
Pain
Pancreatitis bacterial (inflammation of pancreas caused by bacterial infection)
Peritonitis bacterial (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs by bacterial)
Photodermatosis (skin disease that is caused by exposure to sunlight)

What are the existing conditions these people have? *

Portopulmonary Hypertension (coexistence of portal and pulmonary hypertension): 5 people, 13.16%
Pain: 5 people, 13.16%
Non-Hodgkin's Lymphoma Stage Ii (malignant (cancer) cells form in the lymph system- stage ii): 2 people, 5.26%
Neuropathy Peripheral (surface nerve damage): 2 people, 5.26%
Indigestion: 2 people, 5.26%
High Blood Cholesterol: 2 people, 5.26%
Dyspnea (difficult or laboured breathing): 2 people, 5.26%
Dry Skin: 2 people, 5.26%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Evista and Lactulose?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously